1. Home
  2. TGHL vs CASI Comparison

TGHL vs CASI Comparison

Compare TGHL & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TGHL
  • CASI
  • Stock Information
  • Founded
  • TGHL 2020
  • CASI 1991
  • Country
  • TGHL Singapore
  • CASI China
  • Employees
  • TGHL N/A
  • CASI N/A
  • Industry
  • TGHL EDP Services
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • TGHL Technology
  • CASI Health Care
  • Exchange
  • TGHL Nasdaq
  • CASI Nasdaq
  • Market Cap
  • TGHL 42.0M
  • CASI 35.8M
  • IPO Year
  • TGHL 2025
  • CASI 1996
  • Fundamental
  • Price
  • TGHL $1.64
  • CASI $1.84
  • Analyst Decision
  • TGHL
  • CASI Strong Buy
  • Analyst Count
  • TGHL 0
  • CASI 1
  • Target Price
  • TGHL N/A
  • CASI $4.00
  • AVG Volume (30 Days)
  • TGHL 171.7K
  • CASI 305.0K
  • Earning Date
  • TGHL 01-01-0001
  • CASI 11-13-2025
  • Dividend Yield
  • TGHL N/A
  • CASI N/A
  • EPS Growth
  • TGHL N/A
  • CASI N/A
  • EPS
  • TGHL N/A
  • CASI N/A
  • Revenue
  • TGHL $173,668.00
  • CASI $31,564,000.00
  • Revenue This Year
  • TGHL N/A
  • CASI N/A
  • Revenue Next Year
  • TGHL N/A
  • CASI N/A
  • P/E Ratio
  • TGHL N/A
  • CASI N/A
  • Revenue Growth
  • TGHL 84.40
  • CASI 36.64
  • 52 Week Low
  • TGHL $1.56
  • CASI $1.09
  • 52 Week High
  • TGHL $4.25
  • CASI $7.50
  • Technical
  • Relative Strength Index (RSI)
  • TGHL N/A
  • CASI 51.04
  • Support Level
  • TGHL N/A
  • CASI $1.77
  • Resistance Level
  • TGHL N/A
  • CASI $2.08
  • Average True Range (ATR)
  • TGHL 0.00
  • CASI 0.20
  • MACD
  • TGHL 0.00
  • CASI 0.02
  • Stochastic Oscillator
  • TGHL 0.00
  • CASI 71.84

About TGHL The GrowHub Limited Class A Ordinary Shares

The Growhub Ltd operates at the intersection of technology and supply chain management in the food industry, focusing on enhancing product traceability and authenticity. With a commitment to innovation and sustainability, It has developed a multi-faceted approach to address industry challenges. its business currently comprises two main divisions, which are the GrowHub Platform and its product trading facilitation offering.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: